(-)-2β-(3-(4-Methylphenyl)isoxazol-5-yl)-3β-(4-chlorophenyl)tropane
220px | |
Systematic (IUPAC) name | |
---|---|
(1R,2S,3S,5S)-8-methyl-2-(3-(4-methylphenyl)isoxazol-5-yl)-3-(4-chlorophenyl)-8-azabicyclo[3.2.1]octane | |
Identifiers | |
PubChem | CID 9800708 |
Chemical data | |
Formula | C24H25ClN2O |
Molar mass | 392.920[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
RTI-336, (LS-193,309, (-)-2β-(3-(4-methylphenyl)isoxazol-5-yl)-3β-(4-chlorophenyl)tropane) is a phenyltropane derivative which acts as a potent and selective dopamine reuptake inhibitor and stimulant drug. It binds to the dopamine transporter with around 20x the affinity of cocaine,[1] however it produces relatively mild stimulant effects, with a slow onset and long duration of action.[2] These characteristics make it a potential candidate for treatment of cocaine addiction, as a possible substitute drug analogous to how methadone is used for treating heroin abuse.[3][4] RTI-336 fully substitutes for cocaine in addicted monkeys and supports self-administration,[5][6] and significantly reduces rates of cocaine use, especially when combined with SSRIs,[7] and research is ongoing to determine whether it could be a viable substitute drug in human cocaine addicts.
See also
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
This pharmacology-related article is a stub. You can help ssf by expanding it. |
- ↑ Carroll, F.; Pawlush, N.; Kuhar, M.; Pollard, G.; Howard, J. (2004). "Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3beta-(substituted phenyl)-2beta-(3'-substituted isoxazol-5-yl)tropanes". Journal of Medicinal Chemistry. 47 (2): 296–302. doi:10.1021/jm030453p. PMID 14711303.
- ↑ Carroll, F.; Fox, B.; Kuhar, M.; Howard, J.; Pollard, G.; Schenk, S. (2006). "Effects of dopamine transporter selective 3-phenyltropane analogs on locomotor activity, drug discrimination, and cocaine self-administration after oral administration". European journal of pharmacology. 553 (1-3): 149–156. doi:10.1016/j.ejphar.2006.09.024. PMID 17067572. More than one of
|author2=
and|last2=
specified (help); More than one of|author3=
and|last3=
specified (help); More than one of|author4=
and|last4=
specified (help); More than one of|author5=
and|last5=
specified (help); More than one of|author6=
and|last6=
specified (help) - ↑ Carroll, F.; Howard, J.; Howell, L.; Fox, B.; Kuhar, M. (2006). "Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse". The AAPS journal. 8 (1): E196–E203. doi:10.1208/aapsj080124. PMC 2751440 Freely accessible. PMID 16584128.
- ↑ Sofuoglu M, Kosten TR. Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opinion on Emerging Drugs. 2006 Mar;11(1):91-98. doi:10.1517/14728214.11.1.91
- ↑ Kimmel, H.; O'Connor, J.; Carroll, F.; Howell, L. (2007). "Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys". Pharmacology, biochemistry, and behavior. 86 (1): 45–54. doi:10.1016/j.pbb.2006.12.006. PMC 1850383 Freely accessible. PMID 17258302.
- ↑ Kimmel, H.; Negus, S.; Wilcox, K.; Ewing, S.; Stehouwer, J.; Goodman, M.; Votaw, J.; Mello, N.; Carroll, F. (2008). "Relationship between rate of drug uptake in brain and behavioral pharmacology of monoamine transporter inhibitors in rhesus monkeys". Pharmacology, biochemistry, and behavior. 90 (3): 453–462. doi:10.1016/j.pbb.2008.03.032. PMC 2453312 Freely accessible. PMID 18468667.
- ↑ Howell, L.; Carroll, F.; Votaw, J.; Goodman, M.; Kimmel, H. (2007). "Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeys". The Journal of pharmacology and experimental therapeutics. 320 (2): 757–765. doi:10.1124/jpet.106.108324. PMID 17105829.
- Pages with script errors
- Pages using duplicate arguments in template calls
- Pages with broken file links
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Cocaine
- Dopamine reuptake inhibitors
- Stimulants
- Tropanes
- 2Fix
- Isoxazoles
- Organochlorides
- Pharmacology stubs
- Pages with citations having redundant parameters